Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 Data collection
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing elderly population
3.2.1.2 Rising awareness and focus about facial aesthetics in developed countries
3.2.1.3 Increasing demand for minimally invasive cosmetic procedures
3.2.1.4 Increasing number of professionals and facilities in developed countries
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with aesthetic injectables
3.2.2.2 Side effects associated with these procedures
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Botulinum toxin
5.2.1 Botulinum toxin A
5.2.2 Botulinum toxin B
5.3 Dermal fillers
5.3.1 By product type
5.3.1.1 Hyaluronic acid
5.3.1.2 Calcium hydroxyapatite
5.3.1.3 Poly-L-lactic acid
5.3.1.4 Polymethyl-methacrylate microspheres (PMMA)
5.3.1.5 Collagen
5.3.1.6 Fat fillers
5.3.1.7 Other dermal fillers
5.3.2 By application
5.3.2.1 Face lift
5.3.2.2 Facial correction
5.3.2.3 Wrinkles reduction
5.3.2.4 Acne scar
5.3.2.5 Lipoatrophy
5.3.2.6 Lip enhancement
5.3.2.7 Hip augmentation
5.3.2.8 Breast enhancement
5.3.2.9 Hand rejuvenation
5.3.2.10 Penis enlargement
5.3.2.11 Blepharoplasty
5.3.2.12 Neck & chin lift
5.3.2.13 Other applications
Chapter 6 Market Estimates and Forecast, By Gender, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Female
6.3 Male
Chapter 7 Market Estimates and Forecast, By Age Group, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 15 – 30
7.3 31 – 40
7.4 41 – 50
7.5 51 – 60
7.6 >60
Chapter 8 Market Estimates and Forecast, By End-user, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Dermatology clinics
8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 AbbVie Inc (Allergan Plc.)
10.2 Bio-Med Private Limited
10.3 Bioxis Pharmaceuticals
10.4 Cytophil, Inc.
10.5 Galderma S.A.
10.6 Ipsen SA
10.7 Laboratories Vivacy SAS
10.8 Merz Pharma GmbH & Co. KGaA.
10.9 Mesoestetic
10.10 Sinclair Pharma (Huadong Medicine Co., Ltd)
10.11 Suneva Medical, Inc
10.12 Teoxane Laboratories
